COMMUNIQUÉS West-GlobeNewswire

ChemioCare Initiates Development Program in Pediatric CINV
04/01/2019
NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery today announced that its Adult Ondansetron 5-day adhesive [...]
Arvinas Receives Authorization to Proceed for its IND Application for PROTAC™ Therapy to Treat Patients with Metastatic Castration-Resistant Prostate Cancer
04/01/2019
Expects Enrollment of Phase 1 Trial to Begin in the First Quarter of 2019 NEW HAVEN, Conn., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on [...]
Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions
04/01/2019
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. , a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/01/2019
BURLINGTON, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to four new employees for an aggregate of 53,700 shares of common stock. [...]
Amarin Provides Preliminary 2018 Results and 2019 Outlook
04/01/2019
U.S. Sales Force Increased to 400 Sales Professionals for 2019 Following Unprecedented Positive Results of Vascepa® Cardiovascular Outcomes Study Presented in November 2018 Unaudited Full-Year 2018 Net Total Revenue [...]
Atara Biotherapeutics to Participate in the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Fibrocor and Galapagos sign partnership in fibrosis
04/01/2019
Mechelen, Belgium; 4 January 2019, 22.01 CET - Fibrocor Therapeutics L.P. (Fibrocor), a privately held Canadian company, and Galapagos NV (Euronext & NASDAQ: GLPG) announced a global partnership focused on a novel [...]
Candel Therapeutics Completes $28.7 Million Series B Financing
04/01/2019
Proceeds to Accelerate Enrollment of Phase 3 Localized Prostate Cancer Clinical Trial and to Advance Late Stage High-Grade Glioma Clinical Program Candel to Expand Clinical Trials in Other Indications AUBURNDALE, Mass [...]
Stryker to host conference call on January 29, 2019
04/01/2019
Kalamazoo, Michigan, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results [...]
VALNEVA : Bilan Semestriel du contrat de liquidité de Valneva SE
04/01/2019
Paris, le 4 janvier 2019 Bilan semestriel du contrat de liquidité VALNEVA contracté avec ODDO & Cie Au titre du contrat de liquidité confié à Oddo Corporate Finance portant sur les actions de la société VALNEVA, à [...]
Spineway: Subscription of 2nd tranche of 100 bonds for a par value of €1M as per the Additional Commitment
04/01/2019
Spineway Subscription of 2nd tranche of 100 bonds convertible into new and/or existing shares ( OCEANE ) with attached warrants for a par value of €1M as per the Additional Commitment. Spineway (the “ Company ”) [...]
Spineway: Souscription de la 2ème tranche de 100 obligations pour un montant nominal d’1 MEUR au titre de l’Engagement Complémentaires
04/01/2019
SPINEWAY Souscription de la 2ème tranche de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d’actions pour un montant nominal d’1 MEUR au [...]
111, Inc. Signs Online Healthcare Project Strategic Framework Agreement with the Kunshan Health Commission
04/01/2019
SHANGHAI, Jan. 04, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online-offline healthcare platform, announced today the signing of a strategic framework agreement with [...]
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
04/01/2019
Large, Blinded Prospective Study Demonstrates that GeneSight Improves Clinical Outcomes in Patients with Treatment Resistant Major Depressive Disorder SALT LAKE CITY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, [...]
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research
04/01/2019
Results Demonstrate an Increased Survival Rate for Patients Treated with Epicel CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports [...]
Indiana Minority Health Coalition in Partnership to Host Second Statewide Town Hall Meeting on Infant Mortality in the Black Community
04/01/2019
Co-Sponsors Include Side Effects Media and the Indianapolis Recorder INDIANAPOLIS, Jan. 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Minority Health Coalition (IMHC) in partnership with Side Effects Media and the [...]
Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
04/01/2019
Company to Release New Survey Findings from C-Suite Leaders on Commercial Spend and Planning and Essentials for a Successful Launch MORRISVILLE, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the [...]
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
04/01/2019
ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 woman in the BLOC [...]
OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands
04/01/2019
WARSAW, Ind., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today their recently [...]

Pages